It can easily be upgraded for clinical applications. Contact us at email@example.com for further details and pricing.
Cells growing in CnT-Prime MSC-XF medium also demonstrate extended longevity, and remain strongly multipotent for at least 4 passages.
The cell population is CD45-/CD31-/CD73+/CD90+/CD105+/CD34+/-, and importantly at least 8% of the cell population remains CD34-positive at passage 4.
Figure: CD34 expression, CnT-PR-MSC-XF medium, passage 4.
adMSC expanded in CnT-Prime MSC-XF medium also maintain strong multipotency for extended periods, with class leading differentiation efficiency after 4 passages in culture.
Figure: CnT-Prime MSC Media demonstrate high adipogenic differentiation efficiency compared with leading competitors after 4 passages in culture. (A) CnT-PR-MSC-CD, (B) CnT-PR-MSC-XF, (C) Mesencult-ACF
Figure: High colony forming efficiency of adMSC maintained in CnT-Prime MSC-XF Medium for 4 passages.
Cells may at any time be switched to the chemically defined #CnT-PR-MSC-CD medium, or induced to differentiate following addition of the necessary differentiation supplements. Please visit the MSC homepage for more information about other Prime MSC products.
For recommended isolation, expansion, differentiation and CFE protocols, please visit the Protocols Section of this website.
The CnT-PR-MSC medium is currently in the beta testing phase. Please contact firstname.lastname@example.org to request your test sample.
A flyer summarising the CnT-Prime MSC expansion media is available here.